Identification of novel molecular mechanisms of HIV latency using forward genetic screens (360G-Wellcome-102199_Z_13_Z)

£159,305

The latent viral reservoir remains the major block to HIV eradication and transcriptional repression is thought to be the predominant mechanism of silencing latent HIV.However, multiple mechanisms of repression are likely to be responsible and finding a cure for HIV is clearly dependent upon an improved understanding of the molecular mechanisms of latent HIV infection. Here, I propose to use forward genetic screens to identify novel genes required for HIV silencing. I will use an HIV-based GFP reporter construct to establish a model of HIV latency in the human near-haploid KBM7 cell line. The KBM7 cells will be mutagenised with a retroviral gene-trap vector, rare GFP-expressing clones will be isolated, and their mutation sites mapped using next generation sequencing. Candidate genes will then be validated in more representative HIV model systems and biochemically characterised to elucidate their mechanism of HIV silencing.

Where is this data from?

This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.

Grant Details

Amount Awarded 159305
Applicant Surname Menzies
Approval Committee PhD Studentships
Award Date 2013-06-24T00:00:00+00:00
Financial Year 2012/13
Grant Programme: Title PhD Studentship (Basic)
Internal ID 102199/Z/13/Z
Lead Applicant Mr Sam Menzies
Partnership Value 159305
Planned Dates: End Date 2017-09-30T00:00:00+00:00
Planned Dates: Start Date 2013-10-01T00:00:00+00:00
Recipient Org: Country United Kingdom
Region East of England
Sponsor(s) Prof Paul Lehner